Drawing for STARGEN

USPTO serial 77252613

STARGEN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with STARGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roberta S. Bren

ROBERTA S. BREN OBLON, SPIVAK, MCCLELLAND, MAIER & NEUSTADT, P.C.1940 DUKE STALEXANDRIA, VA 22314-3451UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Gene therapy and prophylaxis products, namely, proteins, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic and angiogenic molecules, all for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eyes; pharmaceutical preparations for treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative diseases of the eye; retroviral vector and retroviral vector manufacturing preparations, namely, pharmaceutical and biochemical preparations for the treatment of degenerative diseases of the eyes, including Stargardt disease and other degenerative retinal diseases; gene based pharmaceutical preparations for the treatment of degenerative diseases of the eyesACTIVE—
042Scientific and medical research and development in respect of diseases of the eye; genetic engineering services; biotechnology services, relating to gene therapy products, namely, development of new technology for others in the field of biotechnology and medical research, namely, development of new technologies for others for diagnosis and treatment of diseases of the eyesACTIVE—
045Licensing of intellectual property in respect of gene therapy productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 4, 2014MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 4, 2014ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 6, 2013GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 6, 2013GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 6, 2013CNSISUSPENSION INQUIRY WRITTEN—
Aug 2, 2013RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 26, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 26, 2013GNSLLETTER OF SUSPENSION E-MAILED—
Jan 26, 2013CNSLSUSPENSION LETTER WRITTEN—
Jan 23, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2013ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 24, 2012GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 24, 2012GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 24, 2012CNSISUSPENSION INQUIRY WRITTEN—
Jul 16, 2012RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 16, 2012GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 16, 2012GNSLLETTER OF SUSPENSION E-MAILED—
Jan 16, 2012CNSLSUSPENSION LETTER WRITTEN—
Jan 13, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 13, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2012ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 22, 2011GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 22, 2011GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 22, 2011CNSISUSPENSION INQUIRY WRITTEN—
Aug 15, 2011RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Feb 15, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 15, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Feb 15, 2011CNSLSUSPENSION LETTER WRITTEN—
Jan 26, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 26, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2011ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 29, 2010GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 29, 2010GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 29, 2010CNSISUSPENSION INQUIRY WRITTEN—
Jul 27, 2010RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 27, 2010ALIEASSIGNED TO LIE—
Jan 25, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 25, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Jan 25, 2010CNSLSUSPENSION LETTER WRITTEN—
Jan 25, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2010ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 7, 2010GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 7, 2010GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 7, 2010CNSISUSPENSION INQUIRY WRITTEN—
Jan 4, 2010RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 29, 2009GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 29, 2009GNSLLETTER OF SUSPENSION E-MAILED—
Jun 29, 2009CNSLSUSPENSION LETTER WRITTEN—
Jun 17, 2009DMCCDATA MODIFICATION COMPLETED—
Jun 5, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2009ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 6, 2008GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 6, 2008GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 6, 2008CNSISUSPENSION INQUIRY WRITTEN—
Nov 13, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 13, 2008ALIEASSIGNED TO LIE—
May 13, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 13, 2008GNSLLETTER OF SUSPENSION E-MAILED—
May 13, 2008CNSLSUSPENSION LETTER WRITTEN—
Apr 18, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2007DOCKASSIGNED TO EXAMINER—
Aug 15, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance